Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
VIVEbiotech logo — Your Lentivirus Specialized Partner

VIVEbiotech

Your Lentivirus Specialized Partner

Founded 2015 Spain Spain 122 employees Growth Total: $45.72M

General Information

Company Name VIVEbiotech
Founded Year 2015
Location Spain Spain
Employees 122
Funding Stage Growth
Business Model B2B, D2C, White Label
Revenue Model Service Fee, Project Based, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with VIVEbiotech. To contact VIVEbiotech, visit vivebiotech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does VIVEbiotech compare?

A PDF of VIVEbiotech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting VIVEbiotech soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About VIVEbiotech

VIVEbiotech, founded in 2015, has established itself as a specialized partner in the biotechnology sector, focusing on the development and manufacturing of lentiviral vectors. Positioned as a GMP Contract Development and Manufacturing Organization (CDMO), the company has carved a niche in delivering research, preclinical, and GMP-grade lentiviral vectors tailored to client specifications across Europe, the USA, and Asia.

As of 01 December 2024, VIVEbiotech secured a substantial €40.00M in Growth Equity VC investment from Ampersand Capital Partners, highlighting investor confidence in the company's robust capabilities and market potential. Their headquarters are located in Spain, a strategic location that underpins their expanding global footprint.

Overall, VIVEbiotech's focus on customer-centric, timely service delivery in the bioproduction landscape positions it as a compelling opportunity for investors keen on advancing cutting-edge biotechnology solutions.

Business keywords: Lentiviral Vectors, GMP Contract Development, Manufacturing Organization, CDMO, Gene Therapy, Preclinical Manufacturing, EMA Guidelines, FDA Guidelines, Haematological Malignancies, Solid Malignancies, Rare Diseases, Customized Solutions, Lentisoma, Non-integrative Lentivirus, Biotechnology Manufacturing

Services & Products

Development and manufacturing of GMP lentiviral vectors
Customized solutions for lentiviral vector production
CDMO services for ex vivo and in vivo applications

Target Customers

Biotech companies Pharmaceutical companies Industries requiring specialized lentiviral vector solutions

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Growth Equity VC €40.00M 1
Ampersand Capital Partners
Ampersand Capital Partners
01 Dec 2024
Seed €1.10M 3
Inveready EASO Ventures
Inveready, EASO Ventures +1
01 Dec 2022
Support Program Undisclosed 1
ADEGI
01 Apr 2022
Late VC $120.00K 1
CDTI Innvierte
01 Jun 2021
Early VC €3.50M 2
Inveready EASO Ventures
Inveready, EASO Ventures
01 Sep 2019
Early VC €1.00M -
01 May 2018
Support Program Undisclosed 1
Bic Gipuzkoa Berrilan, S.A.
Bic Gipuzkoa Berrilan, S.A.
01 Jun 2016

VIVEbiotech Alternatives & Competitors

VIVEbiotech vs
RoslinCT
RoslinCT United Kingdom

Your Advanced Cell & Gene Therapy CDMO Partner

Private Equity
350 employees
Biotechnology, Manufacturing
Compare VIVEbiotech vs RoslinCT

FAQ About VIVEbiotech

Your Lentivirus Specialized Partner
VIVEbiotech was founded in 2015.
VIVEbiotech is headquartered in Spain.
VIVEbiotech has a B2B, D2C and White Label business model. Its revenue comes from Service Fee, Project Based and Usage Based.
VIVEbiotech has approximately 122 employees.
VIVEbiotech has completed 7 funding rounds, raising a total of $45.72M. The latest funding stage is Growth.
VIVEbiotech offers: Development and manufacturing of GMP lentiviral vectors, Customized solutions for lentiviral vector production, CDMO services for ex vivo and in vivo applications.
Top alternatives and competitors to VIVEbiotech include RoslinCT. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
VIVEbiotech and RoslinCT are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for VIVEbiotech, https://bouncewatch.com/company/vivebiotech, updated 2 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes